Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Influence of diabetes on left ventricular systolic and diastolic function and on long-term outcome after cardiac resynchronization therapy.

Höke U, Thijssen J, van Bommel RJ, van Erven L, van der Velde ET, Holman ER, Schalij MJ, Bax JJ, Delgado V, Marsan NA.

Diabetes Care. 2013 Apr;36(4):985-91. doi: 10.2337/dc12-1116. Epub 2012 Dec 5.

2.

Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up.

Ypenburg C, van Bommel RJ, Borleffs CJ, Bleeker GB, Boersma E, Schalij MJ, Bax JJ.

J Am Coll Cardiol. 2009 Feb 10;53(6):483-90. doi: 10.1016/j.jacc.2008.10.032.

3.

Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.

Linde C, Gold MR, Abraham WT, St John Sutton M, Ghio S, Cerkvenik J, Daubert C; REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction Study Group.

Eur Heart J. 2013 Sep;34(33):2592-9. doi: 10.1093/eurheartj/eht160. Epub 2013 May 2.

PMID:
23641006
4.

Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADIT-CRT trial.

Pouleur AC, Knappe D, Shah AM, Uno H, Bourgoun M, Foster E, McNitt S, Hall WJ, Zareba W, Goldenberg I, Moss AJ, Pfeffer MA, Solomon SD; MADIT-CRT Investigators.

Eur Heart J. 2011 Jul;32(14):1720-9. doi: 10.1093/eurheartj/ehr185. Epub 2011 May 24.

PMID:
21609974
5.

Relationship between left ventricular dyssynchrony and reverse remodeling after cardiac resynchronization therapy.

Celikyurt U, Vural A, Sahin T, Kilic T, Agacdiken A, Ural D.

Clin Cardiol. 2011 Oct;34(10):645-8. doi: 10.1002/clc.20941. Epub 2011 Sep 12.

6.

Right ventricular function and survival following cardiac resynchronisation therapy.

Leong DP, Höke U, Delgado V, Auger D, Witkowski T, Thijssen J, van Erven L, Bax JJ, Schalij MJ, Marsan NA.

Heart. 2013 May;99(10):722-8. doi: 10.1136/heartjnl-2012-303076. Epub 2013 Jan 12.

PMID:
23315608
7.

Effectiveness of cardiac resynchronization therapy in diabetic patients with ischemic and nonischemic cardiomyopathy.

George J, Barsheshet A, Moss AJ, Martin D, Ouellet G, McNitt S, Goldenberg I.

Ann Noninvasive Electrocardiol. 2012 Jan;17(1):14-21. doi: 10.1111/j.1542-474X.2011.00476.x.

PMID:
22276624
8.

Short-term systolic and diastolic ventricular performance after surgical ventricular restoration for dilated ischemic cardiomyopathy.

Bové T, Van Belleghem Y, Vandenplas G, Caes F, François K, De Backer J, De Pauw M, Van Nooten G.

Eur J Cardiothorac Surg. 2009 Jun;35(6):995-1003; discussion 1003. doi: 10.1016/j.ejcts.2008.11.007. Epub 2009 Jan 10.

PMID:
19136274
9.

Acute effects of withdrawal of cardiac resynchronization therapy on left and right ventricular function, dyssynchrony, and contractile function in patients with New York Heart Association functional class I/II heart failure: MADIT-CRT.

Knappe D, Pouleur AC, Shah AM, Bourgoun M, Brown MW, Foster E, Pfeffer MA, Moss AJ, Solomon SD; MADIT-CRT Investigators.

J Card Fail. 2013 Mar;19(3):149-55. doi: 10.1016/j.cardfail.2013.01.004. Epub 2013 Feb 4.

PMID:
23482074
10.

Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.

Daubert C, Gold MR, Abraham WT, Ghio S, Hassager C, Goode G, Szili-Török T, Linde C; REVERSE Study Group.

J Am Coll Cardiol. 2009 Nov 10;54(20):1837-46. doi: 10.1016/j.jacc.2009.08.011. Epub 2009 Oct 1.

11.

Association of intraventricular mechanical dyssynchrony with response to cardiac resynchronization therapy in heart failure patients with a narrow QRS complex.

van Bommel RJ, Tanaka H, Delgado V, Bertini M, Borleffs CJ, Ajmone Marsan N, Holzmeister J, Ruschitzka F, Schalij MJ, Bax JJ, Gorcsan J 3rd.

Eur Heart J. 2010 Dec;31(24):3054-62. doi: 10.1093/eurheartj/ehq334. Epub 2010 Sep 23.

12.

The effect of cardiac resynchronization therapy on left ventricular diastolic function assessed with speckle-tracking echocardiography.

Shanks M, Antoni ML, Hoke U, Bertini M, Ng AC, Auger D, Marsan NA, van Erven L, Holman ER, Schalij MJ, Bax JJ, Delgado V.

Eur J Heart Fail. 2011 Oct;13(10):1133-9. doi: 10.1093/eurjhf/hfr115. Epub 2011 Aug 25.

13.

Effect of cardiac resynchronization therapy on subendo- and subepicardial left ventricular twist mechanics and relation to favorable outcome.

Bertini M, Delgado V, Nucifora G, Marsan NA, Ng AC, Shanks M, Van Bommel RJ, Borleffs CJ, Ewe SH, Boriani G, Biffi M, Schalij MJ, Bax JJ.

Am J Cardiol. 2010 Sep 1;106(5):682-7. doi: 10.1016/j.amjcard.2010.04.026. Epub 2010 Jul 23.

PMID:
20723646
14.

Cardiac resynchronization therapy in adult patients with repaired tetralogy of fallot and left ventricular systolic dysfunction.

Merchant FM, Kella D, Book WM, Langberg JJ, Lloyd MS.

Pacing Clin Electrophysiol. 2014 Mar;37(3):321-8. doi: 10.1111/pace.12284. Epub 2013 Oct 25.

PMID:
24164147
15.

Morbidity and mortality in heart failure patients treated with cardiac resynchronization therapy: influence of pre-implantation characteristics on long-term outcome.

van Bommel RJ, Borleffs CJ, Ypenburg C, Marsan NA, Delgado V, Bertini M, van der Wall EE, Schalij MJ, Bax JJ.

Eur Heart J. 2010 Nov;31(22):2783-90. doi: 10.1093/eurheartj/ehq252. Epub 2010 Aug 7.

PMID:
20693544
16.

Acute improvement of left ventricular relaxation as a predictor of volume reduction after cardiac resynchronization therapy: a pilot study assessing the value of left ventricular hemodynamic parameter.

Kato H, Shimano M, Sumi T, Murakami H, Kada K, Inden Y, Tsuboi N, Murohara T.

Pacing Clin Electrophysiol. 2014 Nov;37(11):1544-52. doi: 10.1111/pace.12478. Epub 2014 Aug 12.

PMID:
25113752
17.

Reverse remodelling induces progressive ventricular resynchronization after cardiac resynchronization therapy 'from vicious to virtuous cycle'.

Matsumoto K, Tanaka H, Okajima K, Hayashi T, Kajiya T, Sugiyama D, Kawai H, Hirata K.

Eur J Echocardiogr. 2011 Oct;12(10):782-9. doi: 10.1093/ejechocard/jer143. Epub 2011 Aug 23.

PMID:
21865225
18.

Differential change in left ventricular mass and regional wall thickness after cardiac resynchronization therapy for heart failure.

Zhang Q, Fung JW, Auricchio A, Chan JY, Kum LC, Wu LW, Yu CM.

Eur Heart J. 2006 Jun;27(12):1423-30. Epub 2006 Apr 13.

PMID:
16682380
19.

Cardiac magnetic resonance evaluation of the impact of interventricular and intraventricular dyssynchrony on cardiac ventricular systolic and diastolic function in patients with isolated left bundle branch block.

Valenti V, Zia MI, Shubayev L, Edelstein S, Supariwala A, Uretsky S, Fantozzi LM, Volpe M, Sciarretta S, Wolff SD.

Am J Cardiol. 2012 Dec 1;110(11):1651-6. doi: 10.1016/j.amjcard.2012.07.036. Epub 2012 Aug 23.

PMID:
22921998
20.

Invasive acute hemodynamic response to guide left ventricular lead implantation predicts chronic remodeling in patients undergoing cardiac resynchronization therapy.

Duckett SG, Ginks M, Shetty AK, Bostock J, Gill JS, Hamid S, Kapetanakis S, Cunliffe E, Razavi R, Carr-White G, Rinaldi CA.

J Am Coll Cardiol. 2011 Sep 6;58(11):1128-36. doi: 10.1016/j.jacc.2011.04.042.

Supplemental Content

Support Center